510 related articles for article (PubMed ID: 24512387)
1. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
[TBL] [Abstract][Full Text] [Related]
2. Abnormal brain iron homeostasis in human and animal prion disorders.
Singh A; Isaac AO; Luo X; Mohan ML; Cohen ML; Chen F; Kong Q; Bartz J; Singh N
PLoS Pathog; 2009 Mar; 5(3):e1000336. PubMed ID: 19283067
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
4. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
Costanzo M; Zurzolo C
Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
[TBL] [Abstract][Full Text] [Related]
5. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
6. The Role of Vesicle Trafficking Defects in the Pathogenesis of Prion and Prion-Like Disorders.
Cherry P; Gilch S
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977678
[TBL] [Abstract][Full Text] [Related]
7. Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.
Singh A; Qing L; Kong Q; Singh N
Neurobiol Dis; 2012 Mar; 45(3):930-8. PubMed ID: 22182691
[TBL] [Abstract][Full Text] [Related]
8. Prions and prion diseases: Insights from the eye.
Singh N; Chaudhary S; Ashok A; Lindner E
Exp Eye Res; 2020 Oct; 199():108200. PubMed ID: 32858007
[TBL] [Abstract][Full Text] [Related]
9. Prions, prionoids and protein misfolding disorders.
Scheckel C; Aguzzi A
Nat Rev Genet; 2018 Jul; 19(7):405-418. PubMed ID: 29713012
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
11. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts.
Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC
Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701
[TBL] [Abstract][Full Text] [Related]
12. Redox control of prion and disease pathogenesis.
Singh N; Singh A; Das D; Mohan ML
Antioxid Redox Signal; 2010 Jun; 12(11):1271-94. PubMed ID: 19803746
[TBL] [Abstract][Full Text] [Related]
13. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
14. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives.
Lee SJ; Lim HS; Masliah E; Lee HJ
Neurosci Res; 2011 Aug; 70(4):339-48. PubMed ID: 21624403
[TBL] [Abstract][Full Text] [Related]
15. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
16. Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders.
Risen SJ; Boland SW; Sharma S; Weisman GM; Shirley PM; Latham AS; Hay AJD; Gilberto VS; Hines AD; Brindley S; Brown JM; McGrath S; Chatterjee A; Nagpal P; Moreno JA
ACS Chem Neurosci; 2024 Apr; 15(7):1533-1547. PubMed ID: 38507813
[TBL] [Abstract][Full Text] [Related]
17. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
[TBL] [Abstract][Full Text] [Related]
18. Pros and cons of a prion-like pathogenesis in Parkinson's disease.
Hilker R; Brotchie JM; Chapman J
BMC Neurol; 2011 Jun; 11():74. PubMed ID: 21689433
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
Mahbub NU; Islam MM; Hong ST; Chung HJ
Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the histo-molecular pathology of human prion disease.
Baiardi S; Rossi M; Capellari S; Parchi P
Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
